For example, MALAT1 knockdown increased the permeability of the blood‐tumor barrier, which might help to improve tumor penetration with therapeutics (160), while restoration of CASC2 expression upregulated PTEN and increased glioma sensitivity to TMZ‐based chemotherapy (161). The gene discussed is MALAT1; the disease is glioma.